Antitrypanosomal Activity of 1,2,3-Triazole-Based Hybrids Evaluated Using In Vitro Preclinical Translational Models
Chagas disease therapy still relies on two nitroderivatives, nifurtimox and benznidazole (Bz), which have important limitations and serious adverse effects. New therapeutic alternatives for this silent disease, which has become a worldwide public health problem, are essential for its control and eli...
Main Authors: | Lorraine Martins Rocha Orlando, Leonardo da Silva Lara, Guilherme Curty Lechuga, Giseli Capaci Rodrigues, Omar Ginoble Pandoli, Druval Santos de Sá, Mirian Claudia de Souza Pereira |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-09-01
|
Series: | Biology |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-7737/12/9/1222 |
Similar Items
-
Use of Nanocarriers Containing Antitrypanosomal Drugs for the Treatment of Chagas Disease
by: Diogo de Freitas Paiva, et al.
Published: (2023-08-01) -
Anti-<i>Trypanosoma cruzi</i> Activity, Mutagenicity, Hepatocytotoxicity and Nitroreductase Enzyme Evaluation of 3-Nitrotriazole, 2-Nitroimidazole and Triazole Derivatives
by: Cheyene Almeida Celestino Menozzi, et al.
Published: (2023-11-01) -
Bioactivity of Novel Pyrazole-Thiazolines Scaffolds against <i>Trypanosoma cruzi</i>: Computational Approaches and 3D Spheroid Model on Drug Discovery for Chagas Disease
by: Leonardo da Silva Lara, et al.
Published: (2022-05-01) -
In Vitro Antioxidant and Antitrypanosomal Activities of Extract and Fractions of <i>Terminalia catappa</i>
by: Sandra Alves de Araújo, et al.
Published: (2023-06-01) -
Antitrypanosomal Alkaloids from the Marine Bacterium Bacillus pumilus
by: Sergio Martínez-Luis, et al.
Published: (2012-09-01)